S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

PIRS Pieris Pharmaceuticals Inc

13.60

-2.53 (-15.69%)

Dec 13 2024 - Closed

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Pieris Pharmaceuticals (NASDAQ:PIRS)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Pieris Pharmaceuticals Charts.

Pieris Pharmaceuticals (NASDAQ:PIRS)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Pieris Pharmaceuticals Charts.

Pieris Pharmaceuticals Inc News

Form 425 - Prospectuses and communications, business combinations
Thursday 12 December 2024 (2 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 12 December 2024 (2 days ago) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 6 December 2024 (1 week ago) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Tuesday 3 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 3 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Thursday 7 November 2024 (1 month ago) • Edgar (US Regulatory)

Palvella Therapeutics Announces First Patient Dosed in SELVA Phase 3 Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Microcystic Lymphatic Malformations
Thursday 7 November 2024 (1 month ago) • GlobeNewswire Inc.

Form DEF 14A - Other definitive proxy statements
Wednesday 6 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Thursday 17 October 2024 (2 months ago) • Edgar (US Regulatory)

Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer
Thursday 17 October 2024 (2 months ago) • GlobeNewswire Inc.

More Pieris Pharmaceuticals Inc News Articles

Eyecity Com (PK)

Tonix Pharmaceuticals

TheGlobe com (PK)

Worldwide NFT (PK)

GNCC Capital (CE)

Anavex Life Sciences

Asia Broadband (PK)

Northwest Biotherapeutics (QB)

Rennova Health (CE)

Lightwave Logic

Elite Pharmaceuticals (QB)

Fannie Mae (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions